Role of PPARã2 polymorphisms in bodyweight regulation

Bibliography

• Moreno-Aliaga MJ, Santos JL, Marti A, Martinez JA: Does weight loss prognosis depend on genetic make-up? Obes. Rev. 6(2), 155.168 (2005)
   Google Scholar
• Abete I, Parra MD, Zulet MA, Martinez JA: Different dietary strategies for weight loss in obesity: role of energy and macronutrient content. Nutr. Res. Rev. 19(1), 5.17 (2006)
   Google Scholar
• Marti A, Moreno-Aliaga MJ, Hebebrand J, Martinez JA: Genes, lifestyles and obesity. Int. J. Obes. Relat. Metab. Disord. 28(Suppl. 3), S29.S36 (2004)
   Google Scholar
• Rosen ED, Spiegelman BM: PPARƒÀ: a nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem. 276(41), 37731.37734(2001)
   Google Scholar
• Ochoa MC, Marti A, Martinez JA: Obesity studies in candidate genes. Med. Clin. (Barc.) 122(14), 542.551(2004)
   Google Scholar
• Issemann I, Green S: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347(6294), 645.650 (1990)
   Google Scholar
• Cecil JE, Watt P, Palmer CN, Hetherington M: Energy balance and food intake: the role of PPARƒÀ gene polymorphisms. Physiol. Behav. 88(3), 227.233 (2006)
   Google Scholar
• Semple RK, Chatterjee VK, OfRahilly S: PPAR ƒÀ and human metabolic disease. J. Clin. Invest. 116(3), 581.589 (2006)
   Google Scholar
• Paracchini V, Pedotti P, Taioli E: Genetics of leptin and obesity: a HuGE review. Am. J. Epidemiol. 162(2), 101.114 (2005)
   Google Scholar
• Stienstra R, Duval C, M ML, Kersten S: PPARs, obesity, and inflammation. PPAR Res. 95974 (2006)
   Google Scholar
• Sharma AM, Staels B: Review: Peroxisome proliferator-activated receptor ƒÀ and adipose tissue . understanding obesityrelated changes in regulation of lipid and glucose metabolism. J. Clin. Endocrinol. Metab. 92(2), 386.395 (2007)
   Google Scholar
• Yen CJ, Beamer BA, Negri C et al.: Molecular scanning of the human peroxisome proliferator activated receptor ã (hPPAR ã) gene in diabetic Caucasians: identification of a Pro12Ala PPAR ã2 missense mutation. Biochem. Biophys. Res. Commun. 241(2), 270–274 (1997)
   Google Scholar
• Deeb SS, Fajas L, Nemoto M et al.: A Pro12Ala substitution in PPARã2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet. 20(3), 284–287 (1998)
   Google Scholar
• Kolehmainen M, Uusitupa MI, Alhava E, Laakso M, Vidal H: Effect of the Pro12Ala polymorphism in the peroxisome proliferatoractivated receptor (PPAR) ã2 gene on the expression of PPARã target genes in adipose tissue of massively obese subjects. J. Clin. Endocrinol. Metab. 88(4), 1717–1722 (2003)
   Google Scholar
• Stumvoll M, Haring H: The peroxisome proliferator-activated receptor-ã;2 Pro12Ala polymorphism. Diabetes 51(8), 2341–2347 (2002)
   Google Scholar
• Schneider J, Kreuzer J, Hamann A, Nawroth PP, Dugi KA: The proline 12 alanine substitution in the peroxisome proliferatoractivated receptor-ã2 gene is associated with lower lipoprotein lipase activity in vivo. Diabetes 51(3), 867–870 (2002)
   Google Scholar
• Stumvoll M, Wahl HG, Loblein K et al.: Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-ã2 gene is associated with increased antilipolytic insulin sensitivity. Diabetes 50(4), 876–881 (2001)
   Google Scholar
• Masud S, Ye S: Effect of the peroxisome proliferator activated receptor-ã gene Pro12Ala variant on body mass index: a meta-analysis. J. Med. Genet. 40(10), 773–780 (2003)
   Google Scholar
• Gonzalez Sanchez JL, Serrano Rios M, Fernandez Perez C, Laakso M, Martinez Larrad MT: Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor ã-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. Eur. J. Endocrinol. 147(4), 495–501(2002)
   Google Scholar
• Doney A, Fischer B, Frew D et al.: Haplotype analysis of the PPARã Pro12Ala and C1431T variants reveals opposing associations with body weight. BMC Genet. 3, 21 (2002)
   Google Scholar
• Swarbrick MM, Chapman CM, McQuillan BM et al.: A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-ã 2 is associated with combined hyperlipidaemia in obesity. Eur. J. Endocrinol. 144(3), 277–282 (2001)
   Google Scholar
• Ahluwalia M, Evans M, Morris K et al.: The influence of the Pro12Ala mutation of the PPAR-ã receptor gene on metabolic and clinical characteristics in treatment-naive patients with Type 2 diabetes. Diabetes Obes. Metab. 4 (6), 376–378 (2002)
   Google Scholar
• Simon I, Vendrell J, Gutierrez C et al.: Pro12Ala substitution in the peroxisome proliferator-activated receptor-ã; is associated with increased leptin levels in women with Type-2 diabetes mellitus. Horm. Res. 58(3), 143–149 (2002)
   Google Scholar
• Evans D, Mann WA, de Heer J et al.: Variation in the gene for human peroxisome proliferator activated receptor ã (PPARã) does not play a major role in the development of morbid obesity. Int. J. Obes. Relat. Metab. Disord. 24(5), 647–651 (2000)
   Google Scholar
• Ek J, Urhammer SA, Sorensen TI et al.: Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-ã2 (PPAR-ã2): divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia 42(7), 892–895 (1999)
   Google Scholar
• Wang C, Zhai F, Chi Y, Wang G: Association of Pro12Ala mutation in peroxisome proliferator-activated receptor ã2 with obesity and diabetes in Chinese population. Wei Sheng Yan Jiu 33(3), 317–320 (2004)
   Google Scholar
• Kao WH, Coresh J, Shuldiner AR et al.: Pro12Ala of the peroxisome proliferatoractivated receptor-ã2 gene is associated with lower serum insulin levels in nonobese African–Americans: the Atherosclerosis Risk in Communities Study. Diabetes 52(6), 1568–1572 (2003).
   Google Scholar
• Ochoa MC, Marti A, Azcona C et al.: Gene–gene interaction between PPAR ã2 and ADR ã3 increases obesity risk in children and adolescents. Int. J. Obes. Relat. Metab. Disord. 28(Suppl. 3), S37–S41 (2004).
   Google Scholar
• Ghoussaini M, Meyre D, Lobbens S et al.: Implication of the Pro12Ala polymorphism of the PPAR-ã2 gene in Type 2 diabetes and obesity in the French population. BMC Med. Genet. 6, 11 (2005).
   Google Scholar
• Hamann A, Munzberg H, Buttron P et al.: Missense variants in the human peroxisome proliferator-activated receptor-ã2 gene in lean and obese subjects. Eur. J. Endocrinol. 141(1), 90–92 (1999).
   Google Scholar
• Marti A, Martinez JA: Genetics of obesity: gene x nutrient interactions. Int. J. Vitam. Nutr. Res. 76(4), 184–193 (2006).
   Google Scholar
• Pihlajamaki J, Vanhala M, Vanhala P, Laakso M: The Pro12Ala polymorphism of the PPAR ã2 gene regulates weight from birth to adulthood. Obes. Res. 12(2), 187–190 (2004).
   Google Scholar
• Labayen I, Moreno LA, Marti A et al.: Effect of the Ala12 allele in the PPARã-2 gene on the relationship between birth weight and body composition in adolescents: the AVENA study. Pediatr. Res. 62(5), 615–619 (2007).
   Google Scholar
• Eriksson JG, Lindi V, Uusitupa M et al.: The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-ã2 gene on insulin sensitivity and insulin metabolism interact with size at birth. Diabetes 51(7), 2321–2324 (2002).
   Google Scholar
• Nieters A, Becker N, Linseisen J: Polymorphisms in candidate obesity genes and their interaction with dietary intake of n-6 polyunsaturated fatty acids affect obesity risk in a sub-sample of the EPICHeidelberg cohort. Eur. J. Nutr. 41(5), 210–221 (2002).
   Google Scholar
• Brand-Herrmann SM, Kuznetsova T, Wiechert A et al.: Alcohol intake modulates the genetic association between HDL cholesterol and the PPARã2 Pro12Ala polymorphism. J. Lipid Res. 46(5), 913–919 (2005).
   Google Scholar
• Marti A, Corbalan MS, Martinez-Gonzalez MA, Forga L, Martinez JA: CHO intake alters obesity risk associated with Pro12Ala polymorphism of PPARã gene. J. Physiol. Biochem. 58(4), 219–220 (2002).
   Google Scholar
• Luan J, Browne PO, Harding AH et al.: Evidence for gene–nutrient interaction at the PPARã; locus. Diabetes 50(3), 686–689 (2001).
   Google Scholar
• Franks PW, Luan J, Browne PO et al.: Does peroxisome proliferator-activated receptor ã; genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level? Metabolism 53(1), 11–16 (2004).
   Google Scholar
• Memisoglu A, Hu FB, Hankinson SE et al.: Interaction between a peroxisome proliferator-activated receptor ã; gene polymorphism and dietary fat intake in relation to body mass. Hum. Mol. Genet. 12(22), 2923–2929 (2003).
   Google Scholar
• Soriguer F, Morcillo S, Cardona F et al.: Pro12Ala polymorphism of the PPARG2 gene is associated with Type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid. J. Nutr. 136(9), 2325–2330 (2006).
   Google Scholar
• Robitaille J, Despres JP, Perusse L, Vohl MC: The PPAR-ã P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Quebec Family Study. Clin. Genet. 63(2), 109–116 (2003).
   Google Scholar
• Hsueh WC, Cole SA, Shuldiner AR et al.: Interactions between variants in the ã3-adrenergic receptor and peroxisome proliferator-activated receptor-ã2 genes and obesity. Diabetes Care 24(4), 672–677 (2001).
   Google Scholar
• Chen TJ, Ji CY, Zheng XY, Hu YH: Association of ã3 adrenergic receptor and peroxisome proliferator-activated receptor ã2 polymorphisms with insulin sensitivity: a twin study. Biomed. Environ. Sci. 20(2), 99–105(2007).
   Google Scholar
• Damcott CM, Moffett SP, Feingold E et al.: Genetic variation in fatty acid-binding protein-4 and peroxisome proliferatoractivated receptor ã interactively influence insulin sensitivity and body composition in males. Metabolism 53(3), 303–309 (2004).
   Google Scholar
• Goyenechea E, Parra MD, Martinez JA: Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferatoractivated- receptor-ã2 gene polymorphisms. Br. J. Nutr. 96(5), 965–972 (2006).
   Google Scholar
• Lindi VI, Uusitupa MI, Lindstrom J et al.: Association of the Pro12Ala polymorphism in the PPAR-ã2 gene with 3-year incidence of Type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes 51(8), 2581–2586 (2002).
   Google Scholar
• Adamo KB, Dent R, Langefeld CD et al.: Peroxisome proliferator-activated receptor ã 2 and acyl-CoA synthetase 5 polymorphisms influence diet response. Obesity 15(5), 1068–1075 (2007).
   Google Scholar
• Vogels N, Mariman EC, Bouwman FG et al.: Relation of weight maintenance and dietary restraint to peroxisome proliferatoractivated receptor ã2, glucocorticoid receptor, and ciliary neurotrophic factor polymorphisms. Am. J. Clin. Nutr. 82(4), 740–746 (2005).
   Google Scholar
• Nicklas BJ, van Rossum EF, Berman DM et al.: Genetic variation in the peroxisome proliferator-activated receptor-ã2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes 50(9), 2172–2176 (2001).
   Google Scholar
• Tok EC, Ertunc D, Bilgin O et al.: PPAR-ã;2 Pro12Ala polymorphism is associated with weight gain in women with gestational diabetes mellitus. Eur. J. Obstet. Gynecol. Reprod. Biol. 129(1), 25–30 (2006).
   Google Scholar
• Wei Q, Jacobs DR Jr, Schreiner PJ et al.: Patterns of association between PPARã; genetic variation and indices of adiposity and insulin action in African–Americans and Whites: the CARDIA Study. J. Mol. Med. 84(11), 955–965 (2006).
   Google Scholar
• Agarwal AK, Garg A: A novel heterozygous mutation in peroxisome proliferatoractivated receptor-ã gene in a patient with familial partial lipodystrophy. J. Clin. Endocrinol. Metab. 87(1), 408–411 (2002).
   Google Scholar
• Hegele RA, Cao H, Frankowski C, Mathews ST, Leff T: PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Diabetes 51(12), 3586–3590 (2002).
   Google Scholar
• Savage DB, Tan GD, Acerini CL et al.: Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-ã. Diabetes 52(4), 910–917 (2003).
   Google Scholar
• Rankinen T, Zuberi A, Chagnon YC et al.: The human obesity gene map: the 2005 update. Obesity 14(4), 529–644 (2006).
   Google Scholar
• Meirhaeghe A, Tanck MW, Fajas L et al.: Study of a new PPARã2 promoter polymorphism and haplotype analysis in a French population. Mol. Genet. Metab. 85(2), 140–148 (2005).
   Google Scholar
• Meirhaeghe A, Fajas L, Helbecque N et al.: A genetic polymorphism of the peroxisome proliferator-activated receptor ã gene influences plasma leptin levels in obese humans. Hum. Mol. Genet. 7 (3), 435–440 (1998).
   Google Scholar
• Tai ES, Corella D, Deurenberg-Yap M et al.: Differential effects of the C1431T and Pro12Ala PPARã; gene variants on plasma lipids and diabetes risk in an Asian population. J. Lipid Res. 45(4), 674–685 (2004).
   Google Scholar
• Orio F Jr, Matarese G, Di Biase S et al.: Exon 6 and 2 peroxisome proliferatoractivated receptor-ã; polymorphisms in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 88(12), 5887–5892 (2003).
   Google Scholar
• Koch M, Rett K, Maerker E et al.: The PPARã2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of Type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects. Diabetologia 42(6), 758–762 (1999).
   Google Scholar
• Arashiro R, Katsuren K, Fukuyama S, Ohta T: Effect of Trp64Arg mutation of the ã3-adrenergic receptor gene and C161T substitution of the peroxisome proliferator activated receptor ã gene on obesity in Japanese children. Pediatr. Int. 45(2), 135–141 (2003).
   Google Scholar
• Moon MK, Cho YM, Jung HS et al.: Genetic polymorphisms in peroxisome proliferator-activated receptor ã are associated with Type 2 diabetes mellitus and obesity in the Korean population. Diabet. Med. 22(9), 1161–1166 (2005).
   Google Scholar
• Hamer OW, Forstner D, Ottinger I et al.: The Pro115Gln polymorphism within the PPAR ã2 gene has no epidemiological impact on morbid obesity. Exp. Clin. Endocrinol. Diabetes 110(5), 230–234 (2002).
   Google Scholar
• Clement K, Hercberg S, Passinge B et al.: The Pro115Gln and Pro12Ala PPAR ã; gene mutations in obesity and Type 2 diabetes. Int. J. Obes. Relat. Metab. Disord. 24(3), 391–393 (2000).
   Google Scholar
• Vaccaro O, Lapice E, Monticelli A et al.: Pro12Ala polymorphism of the PPARã2 locus modulates the relationship between energy intake and body weight in Type 2 diabetic patients. Diabetes Care 30(5), 1156–1161 (2007).
   Google Scholar
• Rosmond R, Chagnon M, Bouchard C: The Pro12Ala PPARã2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men. Diabetes Metab. Res. Rev. 19(2), 159–163 (2003).
   Google Scholar
• Cole SA, Mitchell BD, Hsueh WC et al.: The Pro12Ala variant of peroxisome proliferator-activated receptor-ã2 (PPAR-ã2) is associated with measures of obesity in Mexican Americans. Int. J. Obes. Relat. Metab. Disord. 24(4), 522–524 (2000).
   Google Scholar
• Beamer BA, Yen CJ, Andersen RE et al.: Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-ã2 gene with obesity in two Caucasian populations. Diabetes 47(11), 1806–1808 (1998).
   Google Scholar
• Valve R, Sivenius K, Miettinen R et al.: Two polymorphisms in the peroxisome proliferator-activated receptor-ã gene are associated with severe overweight among obese women. J. Clin. Endocrinol. Metab. 84(10), 3708–3712 (1999).
   Google Scholar
• Meirhaeghe A, Fajas L, Helbecque N et al.: Impact of the peroxisome proliferator activated receptor ã2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int. J. Obes. Relat. Metab. Disord. 24(2), 195–199 (2000).
   Google Scholar
• Koumanis DJ, Christou NV, Wang XL, Gilfix BM: Pilot study examining the frequency of several gene polymorphisms in a morbidly obese population. Obes. Surg. 12(6), 759–764 (2002).
   Google Scholar
• Sramkova D, Kunesova M, Hainer V et al.: Is a Pro12Ala polymorphism of the PPARã2 gene related to obesity and Type 2 diabetes mellitus in the Czech population? Ann. NY Acad. Sci. 967, 265–273 (2002).
   Google Scholar
• Vaccaro O, Mancini FP, Ruffa G et al.: Pro12Ala mutation in the peroxisome proliferator-activated receptor ã2 (PPARã2) and severe obesity: a case–control study. Int. J. Obes. Relat. Metab. Disord. 24(9), 1195–1199 (2000).
   Google Scholar
• Buzzetti R, Petrone A, Ribaudo M et al.: The common PPAR-ã2 Pro12Ala variant is associated with greater insulin sensitivity. Eur. J. Hum. Genet. 12(12), 1050–1054 (2004).
   Google Scholar
• Moffett SP, Feingold E, Barmada MM et al.: The C161-->T polymorphism in peroxisome proliferator-activated receptor ã, but not P12A, is associated with insulin resistance in Hispanic and non-Hispanic White women: evidence for another functional variant in peroxisome proliferator-activated receptor ã. Metabolism 54(11), 1552–1556 (2005).
   Google Scholar
• Zouari Bouassida K, Chouchane L, Jellouli K et al.: The peroxisome proliferator activated receptorã2 (PPARã2) Pro12Ala variant: lack of association with Type 2 diabetes in obese and non obese Tunisian patients. Diabetes Metab. 31(2), 119–123 (2005).
   Google Scholar
• Nelson TL, Fingerlin TE, Moss L et al.: The PPAR໵ Pro12Ala polymorphism is not associated with body mass index or waist circumference among hispanics from Colorado. Ann. Nutr. Metab. 51(3), 252–257 (2007).
   Google Scholar
• Fu M, Chen H, Li X et al.: Association of Pro12Ala variant in peroxisome proliferator-activated receptor-໵2 gene with Type 2 diabetes mellitus. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 19(3), 234–238 (2002).
   Google Scholar
• Kim KS, Choi SM, Shin SU, Yang HS, Yoon Y: Effects of peroxisome proliferatoractivated receptor-໵ 2 Pro12Ala polymorphism on body fat distribution in female Korean subjects. Metabolism 53(12), 1538–1543 (2004).
   Google Scholar
• Kawasaki I, Tahara H, Emoto M et al.: Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) ໵2 on obesity and insulin resistance in Japanese Type 2 diabetic and healthy subjects. Osaka City Med. J. 48(1), 23–28 (2002).
   Google Scholar
• Oh EY, Min KM, Chung JH et al.: Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-ã2 in Korean diabetic and obese subjects. J. Clin. Endocrinol. Metab. 85(5), 1801–1804 (2000).
   Google Scholar
• Danawati CW, Nagata M, Moriyama H et al.: A possible association of Pro12Ala polymorphism in peroxisome proliferatoractivated receptor ã2 gene with obesity in native Javanese in Indonesia. Diabetes Metab. Res. Rev. 21(5), 465–469 (2005).
   Google Scholar
• Li L, Cheng LX, Nsenga R, He MA, Wu TC: Association between Pro12Ala polymorphism of peroxisome proliferatoractivated receptor-ã 2 and myocardial infarction in the Chinese Han population. Clin. Cardiol. 29(7), 300–304 (2006).
   Google Scholar
• Takata N, Awata T, Inukai K et al.: Pro12Ala substitution in peroxisome proliferator-activated receptor ã2 is associated with low adiponectin concentrations in young Japanese men. Metabolism 53(12), 1548–1551 (2004).
   Google Scholar
• Rosado EL, Bressan J, Hernandez JA, MartinsMF, Cecon PR: Effect of diet and PPARã2 and ã2-adrenergic receptor genes on energy metabolism and body composition in obese women. Nutr. Hosp. 21(3), 317–331 (2006).
   Google Scholar
• Lindi V, Sivenius K, Niskanen L, Laakso M, Uusitupa MI: Effect of the Pro12Ala polymorphism of the PPAR-ã2 gene on longterm weight change in Finnish non-diabetic subjects. Diabetologia 44(7), 925–926 (2001).
   Google Scholar
• Maeda A, Gohda T, Funabiki K, Horikoshi S, Tomino Y: Peroxisome proliferator-activated receptor ã gene polymorphism is associated with serum triglyceride levels and body mass index in Japanese Type 2 diabetic patients. J. Clin. Lab. Anal. 18(6), 317–321 (2004).
   Google Scholar
• Ristow M, Muller-Wieland D, Pfeiffer A, Krone W, Kahn CR: Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N. Engl. J. Med. 339(14), 953–959 (1998).
   Google Scholar
• Bluher M, Paschke R: Analysis of the relationship between PPAR-ã2 gene variants and severe insulin resistance in obese patients with impaired glucose tolerance. Exp. Clin. Endocrinol. Diabetes 111(2), 85–90 (2003).
   Google Scholar